These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12553260)

  • 1. [A novel high quality specific antithrombotic drug--hirudin].
    Li T; Wan C; Li Y; Chen H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1998 Sep; 15(3):306-10. PubMed ID: 12553260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacology of recombinant hirudin].
    Kaiser B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):841-9. PubMed ID: 2483701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comeback of hirudin--an old-established anticoagulant agent.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):10-23. PubMed ID: 2459000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.
    Meng M; Liu Y; Wang YB; Wang JC; Zhang H; Wang XQ; Zhang X; Lu WL; Zhang Q
    J Control Release; 2008 Jun; 128(2):113-9. PubMed ID: 18423766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hirudins--new antithrombotic agent.
    Katira R; Puri VK
    J Assoc Physicians India; 1994 Mar; 42(3):240-1. PubMed ID: 7860517
    [No Abstract]   [Full Text] [Related]  

  • 8. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
    Markwardt F; Hauptmann J; Nowak G; Klessen C; Walsmann P
    Thromb Haemost; 1982 Jun; 47(3):226-9. PubMed ID: 7112494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticoagulant and antithrombotic properties of hirudins.
    Märki WE; Wallis RB
    Thromb Haemost; 1990 Nov; 64(3):344-8. PubMed ID: 2096484
    [No Abstract]   [Full Text] [Related]  

  • 11. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of different anticoagulants on thrombin generation.
    Petros S; Siegemund T; Siegemund A; Engelmann L
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
    Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombotic and thrombolytic effectiveness of rhirudin in mcrovessels].
    Menger MD; Rösken F; Rücker M; Seiffge D; Vollmar B
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):19-20. PubMed ID: 14518203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the controlled release systems of hirudin].
    Li T; Wan C; Li Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1998 Dec; 15(4):419-23. PubMed ID: 12552793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of phage-displayed library by DNA shuffling and the screening of potent hirudin variants].
    Long Y; Liu JY; Liu L; Wang ZR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):167-70. PubMed ID: 16507250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombin as a common target of action for antithrombotic drugs in vivo].
    Ma X
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):646-8. PubMed ID: 1963361
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin.
    Galán AM; van Heerde WL; Escolar G; Ordinas A; Sixma J; de Groot PG
    Eur J Clin Invest; 2006 Sep; 36(9):633-9. PubMed ID: 16919046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
    Halperin JL
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.